StockData
CytoMed Therapeutics Ltd logo

CytoMed Therapeutics Ltd (GDTC) stock

GDTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 4/30
$0.83+0.05 (+6.00%)

Close on Nov 18, 2026Market cap $9.82MP/E –Yield –

CytoMed Therapeutics cash

Cash and short-term investments held at the end of each period.

CytoMed Therapeutics's cash was 2.10M SGD at Dec 31, 2025. For fiscal 2025 it was 2.10M SGD, down 55.4% from the year before. The highest annual figure on record is 6.22M SGD in fiscal 2023.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 20252.10M SGD-55.4%
FY2024Dec 31, 20244.70M SGD-24.5%
FY2023Dec 31, 20236.22M SGD+294.0%
FY2022Dec 31, 20221.58M SGD-37.1%
FY2021Dec 31, 20212.51M SGD+183.8%
FY2020Dec 31, 2020885.27K SGD+138.7%
FY2019Dec 31, 2019370.94K SGD–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 20252.10M SGD-16.6%
Q4 FY2024Dec 31, 20244.70M SGD+430.6%
Q4 FY2023Dec 31, 20236.22M SGD+1577.9%
Q4 FY2022Dec 31, 20221.58M SGD–
Q4 FY2021Dec 31, 20212.51M SGD–
Q4 FY2020Dec 31, 2020885.27K SGD–
Q4 FY2019Dec 31, 2019370.94K SGD–

More CytoMed Therapeutics figures

See a number that looks wrong?